Halper Sadeh Launches Investigations into Four Corporate Acquisitions

The firm is examining whether the proposed terms of these transactions adequately protect ordinary shareholders or if they unfairly favor insiders. Concerns center on whether the deals—which include Iridium’s sale to Rocket Lab, Theravance’s acquisition by Zymeworks, Synaptics’ merger with onsemi, and Bio-Techne’s sale to Merck KGaA—contain restrictive provisions that could stifle superior competing offers. By questioning the fairness of these buyouts, the firm intends to pursue increased consideration or improved disclosures for investors.

Halper Sadeh LLC, located at One World Trade Center, represents global investors in matters of securities fraud and corporate misconduct. Shareholders impacted by these transactions are being invited to review their legal rights regarding potential relief or compensation. The firm operates on a contingent fee basis, meaning participants do not incur out-of-pocket legal expenses during the investigative process.